Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its… Nov 30, 2021
Catching Up With PharmaDrug CEO Daniel Cohen On COVID-19 Treatments And Psychedelic Research Strategy Nov 23, 2021
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple… Nov 18, 2021
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases Nov 5, 2021
PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of… Sep 28, 2021
